Genmab — Maj 2016
-
-
Mystisk. Ikke her.
-
Er der nogle der adgang til den her artikel om et aktie split?http://medwatch.dk/secure/Medicinal___Biotek/article8650831.ece or står der noget nyt i den eller er det ren spekulation som vi også har gjort herinde?
-
Men der er embargo på Plenary abstracts (bl.a. Castor abstract lba4), som først ophæves 5. juni kl. 16.30 da tid. http://am.asco.org/policies-and-exceptions
-
Selve fremlæggelsen af Castor - lba4 - starter 5. juni kl. 22.10 da tid og varer 15 min. https://iplanner.asco.org/am2016/#/session/11252
-
Link til partnership med Aduro http://www.genmab.com/partnering/current-partnerships#tab3.
-
Se under fanen Technology Partnerships fjerdesidste afsnit.
-
-
Daratumumab is basically being combined with just about anything that you can think of in the context of phase III studies http://global.onclive.com/insights/Immunotherapy-in-multiple-myeloma/antibodies-in-combination-therapy-for-myeloma
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind